✦ LIBER ✦

Intermediate versus hard end points in clinical trials on hypertension

✍ Scribed by Guido Grassi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

End Points and Clinical Trial Design in

✍ Vallerie V. McLaughlin; David B. Badesch; Marion Delcroix; Thomas R. Fleming; Se 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 350 KB

End points and clinical trial designs in

✍ Marius M Hoeper; Ronald J Oudiz; Andrew Peacock; Victor F Tapson; Sheila G Hawor 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

On the design and analysis of randomized

✍ Nancy L. Geller; Del-In Tang; Stuart J. Pocock 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 76 KB

A Prospective Randomized Trial of 0.010″

✍ J. DAVID TALLEY; PATRICK D. MAULDIN; MASSOUD-A. LEESAR; EDMUND R. BECKER 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 998 KB

Effects of Prolonged-Release Torasemide

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 1018 KB

Strength of conclusion attained from a c

✍ David H. Spodick 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 131 KB